Stroke Prevention in Atrial Fibrillation II "SPAF II"

Completed

Phase N/A Results

Results

In the younger patients, warfarin decreased the absolute rate of primary events by 0.7% per year. In older patients, warfarin decreased the absolute rate of primary events by 1.2%.